Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from IDT Australia Limited ( (AU:IDT) ) is now available.
IDT Australia Limited has announced its Annual General Meeting (AGM) scheduled for 19 November 2025, which will be conducted as a hybrid meeting allowing both in-person and virtual attendance. This meeting is significant for shareholders as it provides an opportunity to engage with the company’s board and participate in decision-making processes, reflecting IDT’s commitment to transparency and shareholder involvement.
More about IDT Australia Limited
IDT Australia Limited operates in the pharmaceutical industry, focusing on the development and manufacturing of pharmaceutical products. The company is known for its expertise in drug formulation and production, catering primarily to the Australian market.
Average Trading Volume: 281,714
Technical Sentiment Signal: Sell
Current Market Cap: A$24.81M
For detailed information about IDT stock, go to TipRanks’ Stock Analysis page.